Peripheral Artery Disease

Peripheral artery disease (PAD) involves atherosclerosis mainly in the extremities, especially in the legs and feet that lead to ischemia. Untreated, PAD can progress to critical limb ischemia (CLI), also called chronic limb-threatening ischemia (CLTI), which will lead to foot or leg amputation. The mortality rate for these CLI amputees is 70% within three years. There is currently an epidemic of PAD and CLI in the U.S. The majority of patients are defined by health disparities concentrated in the Black, Latino, Native American populations in both rural and low-income urban areas. A large number of PAD patients have other comorbities, with diabetes being one a primary issue.

Map of Congressional districts and the rate of amputations based on medicare data showing Mississippi delta region with the highest number of amputation procedures per year. Dr. Fakorede located his practice there to try and combat extremely the high PAD and CLI rates.

PAD is a public health crisis say cardiovascular societies

September is peripheral artery disease (PAD) awareness month, and medical societies are using it to promote awareness for patients and referring physicians to act against the debilitating disease.
 

AI-based CAD assessments dramatically improve vascular surgery outcomes

PAD patients evaluated with HeartFlow's noninvasive FFRCT Analysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years. 

On the frontline of the epidemic of peripheral artery disease (PAD) and related 400 leg amputations per day in the U.S., Kumar Madassery, MD, director of peripheral vascular intervention and critical limb ischemia (CLI) program at Rush University Medical Center in Chicago, explains there is a glaring health inequities in rural and low income areas of the country.

Peripheral artery disease is out of control in many rural, low income communities

Peripheral artery disease (PAD) leads to more than 400 leg amputations per day in the U.S. Kumar Madassery, MD, discussed the importance of increasing awareness and reaching patients before it is too late. 

Multimodality imaging uncovers ‘landmarks’ for peripheral arterial disease recovery

These new recovery milestones will allow clinicians to pinpoint whether or not a patient is responding to therapy or making the necessary strides toward rehabilitation.

Around the web

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.

HeartFlow kicked off TCT 2024 by sharing new research on the long-term impact of its FFRCT Analysis and Plaque Analysis software.

Significant fluctuations in PET and CT reimbursement rates have made it especially challenging to keep up with this complex topic. We spoke to an expert to learn more.

Trimed Popup
Trimed Popup